ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,13862
-0,55%
Bitcoin
69.045,80
0,75%
Brent Oil
81,965
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Biotie Therapies Corp. (MM) (BITI)

  7. Biotie Therapies Corp. (MM) (BITI) Notícias

BITI

BIOTIE THERAPIES CORP. (BITI)

Biotie Therapies Corp. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BITI
DataHoraFonteTítuloCódigoCompanhia
13/06/201617:56Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BITIBiotie Therapies Corp. (MM)
13/06/201610:30Business WireBiotie Therapies Corp. Announces That the Delisting of Its American Depositary Shares from NASDAQ Global Select Market Has Be...NASDAQ:BITIBiotie Therapies Corp. (MM)
02/06/201617:54Edgar (US Regulatory)(25)NASDAQ:BITIBiotie Therapies Corp. (MM)
04/05/201607:07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
04/05/201607:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
02/05/201617:48Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
02/05/201610:02Business WireFinal Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary ...NASDAQ:BITIBiotie Therapies Corp. (MM)
25/04/201617:37Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BITIBiotie Therapies Corp. (MM)
18/04/201617:01Business WireCompletion of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued & Outstanding Shares, American Depositary Sha...NASDAQ:BITIBiotie Therapies Corp. (MM)
15/04/201607:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
13/04/201610:00Business WireFinal Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued & Outstanding Shares, American Depositary ...NASDAQ:BITIBiotie Therapies Corp. (MM)
11/04/201609:59Business WireAcorda Therapeutics Announces Preliminary Tender Offer Results & Acceptance of the Shares, American Depositary Shares, Stock ...NASDAQ:BITIBiotie Therapies Corp. (MM)
22/03/201618:13Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:BITIBiotie Therapies Corp. (MM)
22/03/201609:03Business WireAcorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued...NASDAQ:BITIBiotie Therapies Corp. (MM)
18/03/201610:03Business WireAcorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued & O...NASDAQ:BITIBiotie Therapies Corp. (MM)
11/03/201608:20Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/03/201608:12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:BITIBiotie Therapies Corp. (MM)
10/03/201614:06Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:BITIBiotie Therapies Corp. (MM)
10/03/201610:40Business WireAcorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued & Outstanding Shares, America...NASDAQ:BITIBiotie Therapies Corp. (MM)
03/03/201618:53Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:BITIBiotie Therapies Corp. (MM)
03/03/201603:30Business WireAcorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisor...NASDAQ:BITIBiotie Therapies Corp. (MM)
17/02/201604:30Business WireAcorda Announces Expiration of the Hart-Scott-Rodino Waiting Period for Its Tender Offer for Biotie TherapiesNASDAQ:BITIBiotie Therapies Corp. (MM)
16/02/201609:09Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BITIBiotie Therapies Corp. (MM)
19/01/201606:09Business WireAcorda Announces a Recommended Cash Tender Offer for All Shares, ADSs and Other Equity Instruments in BiotieNASDAQ:BITIBiotie Therapies Corp. (MM)
19/01/201605:50Business WireAcorda to Acquire Biotie TherapiesNASDAQ:BITIBiotie Therapies Corp. (MM)
20/08/201517:37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BITIBiotie Therapies Corp. (MM)
12/06/201512:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/06/201518:07Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/06/201507:08Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/06/201507:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BITIBiotie Therapies Corp. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:BITI

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
AMER3
Americanas ON
BOV
GOLL4
GOL PN
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados